Exploring the differentiation of iPSC to trunk tenocytes and how the single-cell RNA sequencing and pathway analysis can assist in making it more specific.
On May 19, 2026, the SEC proposed sweeping reforms to the process by which US public companies raise capital in SEC-registered offerings, and to ...
Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to ...
On May 19, 2026, the U.S. Securities and Exchange Commission (SEC) issued a proposal (the “Proposal”) that would significantly simplify the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results